Bath & Body Works (NYSE:BBWI) Downgraded by Zacks Investment Research to “Sell”

Zacks Investment Research downgraded shares of Bath & Body Works (NYSE:BBWIGet Rating) from a hold rating to a sell rating in a report published on Wednesday, Zacks.com reports.

According to Zacks, “Bath & Body Works is a specialty retailers and home to America’s Favorite Fragrances(R) offering exclusive fragrances for the body and home, fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap. Bath & Body Works, formerly known as L BRANDS INC, is based in COLUMBUS, Ohio. “

A number of other brokerages have also recently issued reports on BBWI. B. Riley lowered their price objective on Bath & Body Works from $76.00 to $67.00 and set a buy rating for the company in a research note on Friday, May 20th. JPMorgan Chase & Co. lowered their price objective on Bath & Body Works from $81.00 to $67.00 in a research note on Monday, May 16th. Wells Fargo & Company lowered their price objective on Bath & Body Works from $85.00 to $70.00 and set an overweight rating for the company in a research note on Tuesday, April 5th. Barclays lowered their price objective on Bath & Body Works from $53.00 to $40.00 and set an equal weight rating for the company in a research note on Friday, May 20th. Finally, Cowen lowered their price objective on Bath & Body Works from $82.00 to $60.00 and set an outperform rating for the company in a research note on Friday, May 20th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and seventeen have given a buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of Buy and a consensus target price of $66.20.

NYSE BBWI opened at $42.45 on Wednesday. Bath & Body Works has a twelve month low of $35.46 and a twelve month high of $82.00. The firm has a market capitalization of $10.12 billion, a PE ratio of 9.25, a P/E/G ratio of 1.11 and a beta of 1.56. The stock’s 50 day moving average is $49.06 and its 200 day moving average is $57.43.

Bath & Body Works (NYSE:BBWIGet Rating) last released its quarterly earnings results on Wednesday, May 18th. The company reported $0.64 earnings per share for the quarter, beating the consensus estimate of $0.53 by $0.11. Bath & Body Works had a negative return on equity of 83.19% and a net margin of 15.41%. On average, research analysts predict that Bath & Body Works will post 3.9 EPS for the current year.

The company also recently disclosed a dividend, which will be paid on Friday, June 17th. Investors of record on Friday, June 3rd will be issued a $0.20 dividend. The ex-dividend date of this dividend is Thursday, June 2nd. Bath & Body Works’s payout ratio is currently 17.43%.

In related news, CFO Wendy C. Arlin sold 6,000 shares of Bath & Body Works stock in a transaction on Tuesday, April 19th. The stock was sold at an average price of $55.00, for a total value of $330,000.00. Following the completion of the sale, the chief financial officer now owns 98,888 shares of the company’s stock, valued at $5,438,840. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 0.37% of the company’s stock.

A number of large investors have recently added to or reduced their stakes in BBWI. Lone Pine Capital LLC bought a new stake in Bath & Body Works during the third quarter valued at about $1,531,646,000. Steadfast Capital Management LP bought a new stake in Bath & Body Works during the third quarter valued at about $468,997,000. Primecap Management Co. CA bought a new stake in Bath & Body Works during the third quarter valued at about $382,655,000. Geode Capital Management LLC bought a new stake in Bath & Body Works during the third quarter valued at about $306,482,000. Finally, Candlestick Capital Management LP bought a new stake in Bath & Body Works during the third quarter valued at about $267,351,000. 97.11% of the stock is owned by institutional investors and hedge funds.

Bath & Body Works Company Profile (Get Rating)

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. The company sells its products under the Bath & Body Works, White Barn, and other brand names through specialty retail stores and websites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.

See Also

Get a free copy of the Zacks research report on Bath & Body Works (BBWI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Bath & Body Works (NYSE:BBWI)

Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.